Jonathan Schechter - 03 Apr 2025 Form 4 Insider Report for Synaptogenix, Inc. (SNPX)

Reporting relationship: Director
Issuer ticker: SNPX
Reported as of: 03 Apr 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 Apr 2025, 17:00:58 UTC
Prior SEC filing: 17 Jul 2024
Next SEC filing: 12 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Robert Weinstein, Attorney-in-fact

Key filing fact

Jonathan Schechter filed Form 4 for Synaptogenix, Inc. (SNPX) on 07 Apr 2025.

Key facts

This page summarizes Jonathan Schechter's Form 4 filing for Synaptogenix, Inc. (SNPX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 07 Apr 2025, 17:00.

Change

Previous filing in this sequence was filed on 17 Jul 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SNPX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +800
Change %
Price: $0.000000
Shares after: 800
Date: 03 Apr 2025
Ownership: Direct
Underlying class: Common Stock, par value $0.0001 per share
Underlying amount: 800
Exercise price: $2.28
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

All of the holder's options shall vest and become immediately exercisable upon the holder's completion of one year of service following April 3, 2025.